NO20012427D0 - Forbedret kjemisk fremgangsmåte og farmasöytisk formulering - Google Patents

Forbedret kjemisk fremgangsmåte og farmasöytisk formulering

Info

Publication number
NO20012427D0
NO20012427D0 NO20012427A NO20012427A NO20012427D0 NO 20012427 D0 NO20012427 D0 NO 20012427D0 NO 20012427 A NO20012427 A NO 20012427A NO 20012427 A NO20012427 A NO 20012427A NO 20012427 D0 NO20012427 D0 NO 20012427D0
Authority
NO
Norway
Prior art keywords
manufacturing
substituted sulphinyl
compound
formula
adjusted
Prior art date
Application number
NO20012427A
Other languages
English (en)
Other versions
NO321275B1 (no
NO20012427L (no
Inventor
Magnus Erickson
Anders Gustavsson
Lars Josefsson
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26663439&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20012427(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from SE9803952A external-priority patent/SE9803952D0/xx
Priority claimed from SE9803953A external-priority patent/SE9803953D0/xx
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20012427D0 publication Critical patent/NO20012427D0/no
Publication of NO20012427L publication Critical patent/NO20012427L/no
Publication of NO321275B1 publication Critical patent/NO321275B1/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/28Sulfur atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Nutrition Science (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)
NO20012427A 1998-11-18 2001-05-16 Forbedret kjemisk fremgangsmate for fremstilling av tungt opploselige alkaliske salter av substituerte heterocykliske sulfinylforbindelser med farmasoytisk doseringsform og fremgangsmate for fremstilling derav. NO321275B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9803952A SE9803952D0 (sv) 1998-11-18 1998-11-18 Pharmaceutical formulation
SE9803953A SE9803953D0 (sv) 1998-11-18 1998-11-18 Improved chemical process
PCT/SE1999/002093 WO2000028975A2 (en) 1998-11-18 1999-11-15 Improved chemical process and pharmaceutical formulation

Publications (3)

Publication Number Publication Date
NO20012427D0 true NO20012427D0 (no) 2001-05-16
NO20012427L NO20012427L (no) 2001-07-09
NO321275B1 NO321275B1 (no) 2006-04-10

Family

ID=26663439

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20012427A NO321275B1 (no) 1998-11-18 2001-05-16 Forbedret kjemisk fremgangsmate for fremstilling av tungt opploselige alkaliske salter av substituerte heterocykliske sulfinylforbindelser med farmasoytisk doseringsform og fremgangsmate for fremstilling derav.

Country Status (18)

Country Link
US (1) US6403616B1 (no)
EP (1) EP1131316B1 (no)
JP (1) JP4610086B2 (no)
KR (1) KR100619200B1 (no)
CN (1) CN100503598C (no)
AT (1) ATE271556T1 (no)
AU (1) AU770633B2 (no)
BR (1) BR9915421A (no)
CA (1) CA2347981C (no)
DE (1) DE69918854T2 (no)
DK (1) DK1131316T3 (no)
ES (1) ES2222754T3 (no)
HK (1) HK1038920B (no)
IL (2) IL142629A0 (no)
NO (1) NO321275B1 (no)
NZ (1) NZ511169A (no)
PT (1) PT1131316E (no)
WO (1) WO2000028975A2 (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
WO2005082888A1 (en) * 2004-03-01 2005-09-09 Milen Merkez Ilac Endustrisi A.S. Process for the preparation of magnesium salt of omeprazole
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8779175B2 (en) 2004-10-25 2014-07-15 Synthonics, Inc. Coordination complexes, pharmaceutical solutions comprising coordination complexes, and methods of treating patients
US20060141054A1 (en) 2004-10-25 2006-06-29 Thomas Piccariello Metal coordinated compositions
US7799937B2 (en) 2004-10-25 2010-09-21 Synthonics, Inc. Metal coordinated compositions
WO2007138606A2 (en) * 2006-06-01 2007-12-06 Dexcel Pharma Technologies Ltd. Multiple unit pharmaceutical formulation
US20090280173A1 (en) * 2008-05-09 2009-11-12 Ishwar Chauhan Multilayer Omeprazole Tablets
EP2708124B1 (en) 2011-11-10 2018-03-21 Rotam Agrochem International Co., Ltd Herbicidal composition and method of using the same
EP3288556A4 (en) 2015-04-29 2018-09-19 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL76839A (en) * 1984-10-31 1988-08-31 Byk Gulden Lomberg Chem Fab Picoline derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
GB2189698A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
DK0519144T3 (da) 1991-06-21 1998-03-23 Ilsan Ilac Ve Hammaddeleri San Ny galenisk proces for omeprazol indeholdende pellets
SE9301830D0 (sv) 1993-05-28 1993-05-28 Ab Astra New compounds
SE9302396D0 (sv) * 1993-07-09 1993-07-09 Ab Astra A novel compound form
SE9302395D0 (sv) * 1993-07-09 1993-07-09 Ab Astra New pharmaceutical formulation
TNSN95062A1 (fr) * 1994-05-27 1996-02-06 Astra Ab Nouveaux derives dialkoxy-pyridinyle-benzimidazole
SE9402431D0 (sv) 1994-07-08 1994-07-08 Astra Ab New tablet formulation
US5945124A (en) 1995-07-05 1999-08-31 Byk Gulden Chemische Fabrik Gmbh Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole
AUPN846496A0 (en) * 1996-03-05 1996-03-28 Research Laboratories Of Australia Pty Ltd Electronic printing for display technology
SE508669C2 (sv) * 1996-04-26 1998-10-26 Astra Ab Nytt förfarande
EP0898712B1 (en) * 1996-05-17 2003-08-06 Formfactor, Inc. Wafer-level burn-in and test
CN1128997C (zh) * 2001-01-04 2003-11-26 中国科学院南京土壤研究所 一种吸力平板的制作方法

Also Published As

Publication number Publication date
HK1038920B (zh) 2005-03-11
IL142629A0 (en) 2002-03-10
DE69918854T2 (de) 2005-07-21
ES2222754T3 (es) 2005-02-01
KR20010089474A (ko) 2001-10-06
DK1131316T3 (da) 2004-09-27
JP2002529497A (ja) 2002-09-10
AU1901700A (en) 2000-06-05
CN100503598C (zh) 2009-06-24
HK1038920A1 (en) 2002-04-04
IL142629A (en) 2007-12-03
DE69918854D1 (de) 2004-08-26
KR100619200B1 (ko) 2006-09-05
NO321275B1 (no) 2006-04-10
EP1131316B1 (en) 2004-07-21
WO2000028975A3 (en) 2000-08-10
US6403616B1 (en) 2002-06-11
PT1131316E (pt) 2004-10-29
JP4610086B2 (ja) 2011-01-12
EP1131316A2 (en) 2001-09-12
ATE271556T1 (de) 2004-08-15
CA2347981C (en) 2010-05-04
CA2347981A1 (en) 2000-05-25
CN1326455A (zh) 2001-12-12
BR9915421A (pt) 2001-08-07
NZ511169A (en) 2003-06-30
NO20012427L (no) 2001-07-09
AU770633B2 (en) 2004-02-26
WO2000028975A2 (en) 2000-05-25

Similar Documents

Publication Publication Date Title
NO20012427D0 (no) Forbedret kjemisk fremgangsmåte og farmasöytisk formulering
NZ527585A (en) Tablets quickly disintegrated in oral cavity
CS261851B2 (en) Process for preparing 2-pyridylmethylsulphinylbenzimidazoles
UA58605C2 (uk) Дигідрат пантопразолу магнію та лікарський засіб на його основі (варіанти)
BR0008221A (pt) Compostos heterocìclicos debenzenosulfonamidas como antagonistasbradykinina
MY131971A (en) Formulation of substituted benzimidazoles
JP2002529497A5 (no)
MY115018A (en) New process for the preparation of ropivacaine hydrochloride monohydrate
BRPI0408675A (pt) derivados de talidomida solúveis em água
MX9703339A (es) Solucion acuosa para infusion, estable al almacenamiento, que contiene un inhibidor de trombina.
AR029002A1 (es) Proceso para preparar compuestos de acidos quinolin-2-carboxilicos y de sus sales farmaceuticamente aceptables
ATE3769T1 (de) 1-imidazol-2-yliden-3-thienyl-harnstoffderivate verfahren zu deren herstellung und pharmazeutische zusammensetzungen.
NZ505080A (en) Pharmaceutical formulations containing a compound having an amidine group stabilized by an acid
NZ584037A (en) Formulation containing cyclin-dependent kinase inhibiting compound and method of treating tumors using the same
EP2264025B1 (en) Method for producing lansoprazole
GB1436502A (en) Amide derivatives of 3-benzoylphenyl-alkanoic acids
TH64461A (th) กระบวนการสำหรับการเตรียม 2-[5-(4-ฟลูออโรฟีนิล)-3-ไพริดิลเมทธิลอะมิโนเมทธิล]โครแมน
GB1188959A (en) 2-Substituted Pyridines as Anthelmintic Agents
SU1189876A1 (ru) Дезинфицирующее средство "дезнор
CN103172544A (zh) 一种精氨酸布洛芬结晶物的制备方法
GB1156854A (en) Lactones of Optically Active Heterocyclic Amino Acids and Process for the Preparation thereof
TH18739A (th) ริสเพอริโดนพาโมเอท
US3737531A (en) N-diaryl-pyridyl-methyl-imidazoles,salts thereof as antifungal agents
GB1244026A (en) Antibacterial agents and process for their preparation
TH3125A (th) สารอนุพันธ์ของควิโนลีนคาร์บอกซิลิคแอซิด และกรรมวิธีในการเตรียมสารนั้น

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees